Advanced search
Publication Cover
International Journal of General Medicine Volume 16, 2023 - Issue
Submit an article Journal homepage
159
Views
0
CrossRef citations to date
0
Altmetric
Oncology

Identification of Hub Genes Associated with Gastric Cancer via Bioinformatics Analysis and Validation Studies

Ting Zhao1 Department of Clinical Pharmacy, The First Affiliated Hospital of Kunming Medical University, Kunming, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-4428-3095View further author information
ORCID Icon,
Zihao Chen2 Department of Surgical Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming, People’s Republic of ChinaView further author information
,
Wenbo Liu3 The Third department of Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of ChinaView further author information
,
Hongping Ju4 School of Medicine, Kunming University, Kunming, People’s Republic of ChinaView further author information
&
Fang Li5 Department of Pathology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 4835-4848 | Received 14 Aug 2023, Accepted 12 Oct 2023, Published online: 26 Oct 2023

References

  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
  • Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet. 2016;388(10060):2654–2664. doi:10.1016/S0140-6736(16)30354-3
  • Tao Z, Shi A, Li R, Wang Y, Wang X, Zhao J. Microarray bioinformatics in cancer- a review. J BUON. 2017;22(4):838–843.
  • Saito M, Momma T, Kono K. Targeted therapy according to next generation sequencing-based panel sequencing. Fukushima J Med Sci. 2018;64(1):9–14. doi:10.5387/fms.2018-02
  • Harada K, Okamoto W, Mimaki S, et al. Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapy. BMC Cancer. 2019;19(1):255. doi:10.1186/s12885-019-5479-6
  • Zhao B, Baloch Z, Ma Y, et al. Identification of potential key genes and pathways in early-onset colorectal cancer through bioinformatics analysis. Cancer Control. 2019;26(1):1073274819831260. doi:10.1177/1073274819831260
  • Cojocneanu R, Braicu C, Raduly L, et al. Plasma and tissue specific miRNA expression pattern and functional analysis associated to colorectal cancer patients. Cancers. 2020;12(4):843. doi:10.3390/cancers12040843
  • Shimizu M, Saitoh Y, Itoh H. Immunohistochemical staining of Ha-ras oncogene product in normal, benign, and malignant human pancreatic tissues. Hum Pathol. 1990;21(6):607–612. doi:10.1016/S0046-8177(96)90006-4
  • Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2021;24(1):1–21. doi:10.1007/s10120-020-01042-y
  • Khan U, Shah MA. Ramucirumab for the treatment of gastric or gastro-esophageal junction cancer. Expert Opin Biol Ther. 2019;19(11):1135–1141. doi:10.1080/14712598.2019.1656715
  • Vrana D, Matzenauer M, Neoral C, et al. From tumor immunology to immunotherapy in gastric and esophageal cancer. Int J Mol Sci. 2018;20(1). doi:10.3390/ijms20010013
  • Winkler J, Abisoye-Ogunniyan A, Metcalf KJ, Werb Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun. 2020;11(1):5120. doi:10.1038/s41467-020-18794-x
  • Sun X, Wu B, Chiang HC, et al. Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion. Nature. 2021;599(7886):673–678. doi:10.1038/s41586-021-04057-2
  • Xu Y, Zhang X, Hu X, et al. The effects of lncRNA MALAT1 on proliferation, invasion and migration in colorectal cancer through regulating SOX9. Mol Med. 2018;24(1):52. doi:10.1186/s10020-018-0050-5
  • Miyake M, Hori S, Morizawa Y, et al. Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladder. Oncotarget. 2017;8(22):36099–36114. doi:10.18632/oncotarget.16432
  • Huang R, Gu W, Sun B, Gao L. Identification of COL4A1 as a potential gene conferring trastuzumab resistance in gastric cancer based on bioinformatics analysis. Mol Med Rep. 2018;17(5):6387–6396. doi:10.3892/mmr.2018.8664
  • Lund-Andersen C, Torgunrud A, Fleten KG, Flatmark K. Omics analyses in peritoneal metastasis-utility in the management of peritoneal metastases from colorectal cancer and pseudomyxoma peritonei: a narrative review. J Gastrointest Oncol. 2021;12(Suppl 1):S191–S203. doi:10.21037/jgo-20-136
  • Giulietti M, Occhipinti G, Righetti A, et al. Emerging biomarkers in bladder cancer identified by network analysis of transcriptomic data. Front Oncol. 2018;8:450. doi:10.3389/fonc.2018.00450
  • He J, Wu F, Han Z, et al. Biomarkers (mRNAs and Non-Coding RNAs) for the diagnosis and prognosis of colorectal cancer - from the body fluid to tissue level. Front Oncol. 2021;11:632834. doi:10.3389/fonc.2021.632834

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.